Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
21 Results for "
antibody-dependent cellular phagocytosis
" in MedChemExpress (MCE) Product Catalog:
Products (21)
21 Results for "antibody-dependent cellular phagocytosis" in MCE Product Catalog:
1
1 Cited Publications
Cat. No.: HY-P9976
CAS No.: 1461640-62-9
Synonyms: ch38SB19; hu38SB19; SAR-650984
1
Target:
Research Areas:
1
Target:
Research Areas:
1
1 Cited Publications
Cat. No.: HY-P9976A
CAS No.: 1461640-62-9
1
1 Cited Publications
Cat. No.: HY-P99381
CAS No.: 1221901-33-2
Target:
Research Areas:
Cat. No.: HY-P9983
CAS No.: 166089-32-3
Synonyms: SGN-33; HuM-195; GLK-33 antibody
Research Areas:
Cat. No.: HY-P991061
CAS No.: 3024486-14-1
Synonyms: CHS-114; SRF-114
Tagmokitug (CHS-114; SRF-114) is a fully human IgG1 antibody targeting CCR8. Tagmokitug selectively binds to human CCR8 (Kd = 502 pM) and mediates the death of CCR8-expressing cells via antibody-dependent cellular cytotoxicity and antibody-dependent cellular phagocytosis. Tagmokitug selectively eliminates intratumoral regulatory T cells, induces tumor growth inhibition, remodels the tumor immune microenvironment, and promotes the differentiation of cytotoxic CD8 + T cell subsets. Tagmokitug can be used for the research of solid tumors .
Cat. No.: HY-P99369
CAS No.: 2187368-16-5
Synonyms: IPH 4102; Anti-KIR3DL2/CD158k Reference antibody (lacutamab)
Cat. No.: HY-P99015
CAS No.: 880486-59-9
Target:
Research Areas:
Cat. No.: HY-P990961
CAS No.: 2850355-87-0
Synonyms: IMM-2510; SYN-2510
Target:
Research Areas:
Cat. No.: HY-P991004
CAS No.: 2923687-56-1
Synonyms: LB-101
Target:
Research Areas:
Itanistomig (LB-101) is a tetravalent bispecific antibody targeting PD-L1 and CD47. Itanistomig blocks PD-L1 and achieves tumor enrichment through binding to PD-L1, and also exerts conditional CD47 blocking activity via cleavage of the hinge linker in the PD-L1-positive tumor microenvironment. Itanistomig induces antibody-dependent cellular phagocytosis in human CD14 + cells and drives tumor regression. Itanistomig can be used in research related to solid tumors .
Cat. No.: HY-P991555
Target:
Research Areas:
Cat. No.: HY-P992391
Synonyms: IPH43
Research Areas:
Cat. No.: HY-P992347
Target:
Research Areas:
Cat. No.: HY-P992158
Cat. No.: HY-P991942
Synonyms: BAY3375968; TPP-23411
Target:
Research Areas:
Cat. No.: HY-P992346
Cat. No.: HY-P991782
Target:
Research Areas:
Cat. No.: HY-P992455
Target:
Research Areas:
Cat. No.: HY-P991954
Target:
Research Areas:
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
